Member Info for RegulatorUK

"But if you sell today, you won't "be on the register on the 11th" so the wording of the RNS sounds like you won't get the divi. That's what I don't understand."

As Lioness points out, there's a difference between the date of a trade (the 'execution date') and the date when the trade is final (the 'settlement date'). This is normally two working days. You remain on the register until the settlement date.

For those who find it difficult to understand:

" ... an investor who buys the stock on its ex-dividend date or later will not be eligible to receive the declared dividend."

Clear now?

Just so everyone is clear:

"Ex-dividend describes a stock that is trading without the value of the next dividend payment. The ex-dividend date or "ex-date" is the day the stock starts trading without the value of its next dividend payment. Typically, the ex-dividend date for a stock is one business day before the record date, meaning that an investor who buys the stock on its ex-dividend date or later will not be eligible to receive the declared dividend. Rather, the dividend payment is made to whoever owned the stock the day before the ex-dividend date."

https://www.investopedia.com/terms/e/ex-dividend.asp

"Share bell the rns says ex divi date is the 10th"

Yep - it seems some people don't know how to read an RNS:

"The Company intends to pay the Special Dividend on 6 January 2021 to Braveheart shareholders on the register on 11 December 2020. The Ordinary Shares will be marked ex dividend on 10 December 2020."

Yeah... whatever... :rolleyes:

It might help if you told us which vaccine you're referring to...

Can you print the content of the article rather than just a link please? The FT is behind a paywall.

Or another tin of bl00dy shortbread... revolting stuff!

"Colin has done his best within his obvious news straight jacket to keep us informed. We have had no real negative news of any scale .... Stop bleating or bail out, simples . Gla."

Yebbut... you've gotta remember that some of these keyboard warriors know how to run a listed, specialised manufacturing and testing company better than the board and the chief exec who are actually doing the job. Or so they think.

Scotland are also doing those working in early years, primary and secondary education.

Just to warn you, you may not get anything. At present they're only being given out to particular groups (primarily those working in primary care, adult social care or domiciliary care).

There are plans to expand the scope but they'll particular demographics.

*Takes one look, closes the door and leaves the kindergarten toddlers to it...*

This is the link Gazza is trying to post:

https://www.gov.uk/government/publications/how-tests-and-testing-kits-for-coronavirus-covid-19-work/target-product-profile-antibody-tests-to-help-determine-if-people-have-recent-infection-to-sars-cov-2-version-2

Most people will be familiar with the contents (it's the TPP for antibody tests) as they have been discussed previously on a number of occasions.

"Bit vague and, until there's more evidence, excludes quite a chunk of the population from getting it."

These will be the people who have a history of severe allergic reactions listed in their medical records (it's a standard question), which is a relatively small percentage of the population. We're not talking about people with mild allergies (which is about 40% of the adult population).

There will potentially be alternative vaccines which will be used, as well.

Both of the people concerned apparently have a history of allergic reactions...

It's also worth noting that the Roche test is not an LFT.

Those are both antigen test. Small orders for validation.

What does that indicate? That testing will be with us long term... which is good for ODX.

"We were able to to approve the Pfizer vaccine because we are not in the EU - arrogance that will kick them where it hurts if it proves to be rushed through"

It was also an out and out lie. MHRA pushed approval through using data provided by the European Medicines Agency (as part of our continuing membership benefits during the transitional period) and using a provision in the EU regulations that has been in place for a decade and in UK legislation since 2012.

Even when MHRA publicly stated what the true position was, Tory ministers kept telling lies on Twitter and on camera.

It's not just AstraZeneca... all vaccine manufacturers are hitting issues (including something as simple as an international shortage of glass vials). The problem is that the government announced call off frameworks as if they were actual contracts (e.g. claiming to have ordered 40 million doses of the Pfizer vaccine when in fact they'd only actually ordered 800,000) has raised public expectations - which will be dashed. And that's before we even get to the impacts of Brexit that will hit in about four weeks time.

Testing is going to be around for a long time yet... particularly when the third wave hits in February/March.

"one of the most important questions would be ‘have you already got anti bodies BEFORE receiving a vaccine ie I don’t need one. As I said earlier, no such apparent test, shown anyway, for the First Lady recipient."

It's not. To a greater extent, it is irrelevant whether or not someone has antibodies before they get vaccinated - they'll get vaccinated anyway (we pre-test for relatively few vaccinations). The key part is testing whether *after* the vaccine, the expected antibodies are showing.